News: Generex Announces Investor Conference Call;
Post# of 36537
(Total Views: 205)
Posted On: 11/16/2018 9:16:55 AM
News: Generex Announces Investor Conference Call; Management to Provide Update on Initiatives & Strategic Plans
9:00 AM ET, 11/16/2018 - Business Wire
MIRAMAR, Fla.--(BUSINESS WIRE)--Nov. 16, 2018-- Generex Biotechnology Corporation (www.generex.com) (OTCQB:GNBT) (http://www.otcmarkets.com/stock/GNBT/quote) today announced that it will hold an investor conference call at 9:00 a.m. Eastern time on Monday, December 3, 2018. The purpose of the conference call will be to provide investors with an update on the Company’s initiatives and strategic plans. Webcast and dial-in information for the call will be announced next week.
Generex President & Chief Executive Officer Joseph Moscato stated: “I will look forward to addressing my fellow stockholders following the November 30 payment of the common stock dividend, along with the rest of the Generex management team, to provide a comprehensive update on your Company’s recent successes and your management team’s near-term and longer-term objectives. We will discuss our recent acquisitions, our growth strategies for NuGenerex Distribution Solutions, as well as the immuno-oncology, diagnostics, and drug delivery platforms.”
Ab
9:00 AM ET, 11/16/2018 - Business Wire
MIRAMAR, Fla.--(BUSINESS WIRE)--Nov. 16, 2018-- Generex Biotechnology Corporation (www.generex.com) (OTCQB:GNBT) (http://www.otcmarkets.com/stock/GNBT/quote) today announced that it will hold an investor conference call at 9:00 a.m. Eastern time on Monday, December 3, 2018. The purpose of the conference call will be to provide investors with an update on the Company’s initiatives and strategic plans. Webcast and dial-in information for the call will be announced next week.
Generex President & Chief Executive Officer Joseph Moscato stated: “I will look forward to addressing my fellow stockholders following the November 30 payment of the common stock dividend, along with the rest of the Generex management team, to provide a comprehensive update on your Company’s recent successes and your management team’s near-term and longer-term objectives. We will discuss our recent acquisitions, our growth strategies for NuGenerex Distribution Solutions, as well as the immuno-oncology, diagnostics, and drug delivery platforms.”
Ab
(0)
(0)Generex Biotechnology Corp. (GNBTQ) Stock Research Links
Scroll down for more posts ▼